Efficacy and safety of fixed dose combination of Sitagliptin, metformin, and pioglitazone in type 2 Diabetes (IMPACT study): a randomized controlled trial

被引：0

作者：

Mondal Aashish

Naskar Arindam

Sheelu Shafiq Siddiqi

Deepak Bhosle

V. J. Mallikarjuna

Dange Amol

Sorate Sanket

Gavali Omkar

Patel Parth

Hasnani Dhruvi

Prasad Durga

Dalwadi Pradeep

Kumar Suresh

Pathak Vaishali

Chaudhari Mayura

Basu Indraneel

Shembalkar Jayashri

Fariooqui Arif

S. K. Raghavendra

Varade Deepak

Thakkar Ravindra

Bhanushali Shaishav

Gaikwad Vijay

Kamran Khan

V. V. Mahajani

A. D. Sharma

Mayur Mayabhate

R. R. Pawar

A. S. Aiwale

Shahavi Vinayaka

机构：

[1] Medical College Kolkata,Rajiv Gandhi Centre for Diabetes and Endocrinology

[2] School of Tropical Medicine,Medical Affairs Department

[3] Aligarh Muslim University,undefined

[4] Devgiri Diabetes Centre,undefined

[5] Sadhana Speciality Clinic,undefined

[6] Lifepoint Multispeciality Hospital,undefined

[7] Sanjeevani Hospital,undefined

[8] Lokamanya Multispeciality Hospital,undefined

[9] Shushrusha Navneet Memorial Hospital,undefined

[10] Rudraksha Institute of medical Sciences,undefined

[11] Help Hospitals Pvt Ltd.,undefined

[12] Nirmal Hospital Pvt Ltd.,undefined

[13] Panimalar Medical College Hospital and Research Institute,undefined

[14] Deoyani Multispeciality Hospital,undefined

[15] Ishwar Institute of Health Care,undefined

[16] Shubham Subhawana Superspeciality Hospital,undefined

[17] Getwell Hospital,undefined

[18] Landmark hospital,undefined

[19] RHTC,undefined

[20] BAJRR Hospital and Research Centre,undefined

[21] VS general hospital,undefined

[22] AIMS hospital,undefined

[23] Govt Medical College,undefined

[24] Nidan Kutir Diabetes,undefined

[25] Samarth Hospital Pvt Ltd.,undefined

[26] Alkem Laboratories Ltd,undefined

来源：

Clinical Diabetes and Endocrinology | / 10卷 / 1期

关键词：

Type 2 diabetes mellitus; IMPACT study; Pioglitazone; Metformin; Sitagliptin; Triple therapy;

D O I：

10.1186/s40842-023-00161-6

中图分类号：

学科分类号：

摘要：

引用

共 108 条

[1]

Kalra S(2020)Fixed-dose combination in management of type 2 diabetes mellitus: expert opinion from an international panel J Family Med Prim Care. 9 5450-5457

[2]

Das AK(2013)Pathophysiologic approach to therapy in patients with newly diagnosed type 2 diabetes Diabetes Care. 36 S127-S138

[3]

Priya G(2020)Pathophysiology of type 2 diabetes mellitus Int J Mol Sci. 21 6275-2012

[4]

Ghosh S(1999)Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK prospective Diabetes study (UKPDS) group JAMA. 281 2005-S63

[5]

Mehrotra RN(2012)Standards of medical care in diabetes-2012 Diabetes Care. 35 S11-962

[6]

Das S(2017)Comparative study on adding pioglitazone or sitagliptin to patients with type 2 diabetes mellitus insufficiently controlled with metformin Open Access Maced J Med Sci. 5 955-895

[7]

DeFronzo RA(2010)Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients Metabo Clin Exp. 59 887-550

[8]

Eldor R(2013)Effect of addition of either sitagliptin or pioglitazone in patients with uncontrolled type 2 diabetes mellitus on metformin: a randomized controlled trial J Pharmacol Pharmacother. 4 27-183

[9]

Abdul-Ghani M(2008)Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes Curr Med Res Opin. 24 537-215

[10]

Galicia-Garcia U(2013)Efficacy and safety of sitagliptin added to ongoing metformin and pioglitazone combination therapy in a randomized, placebo-controlled, 26-week trial in patients with type 2 diabetes J Diabetes Complicat. 27 177-120

← 1 2 3 4 5 6 7 8 9 10 →